Wallace Eli M.

Wallace Eli M. is listed in filings as Chief Executive Officer at BridgeBio Oncology Therapeutics Inc.. This profile follows SEC Form 4 activity through Jan 5, 2026, including 4 public disclosures. Recent filings connect the profile to BridgeBio Oncology Therapeutics Inc. (BBOT). The current snapshot covers public activity from Aug 28, 2025 to Jan 5, 2026. Reported amounts are shown as $4.8M to $13.9M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.